MHC class II α/β heterodimeric cell surface molecules expressed from a single proviral genome

Human Gene Therapy

Volumn 10, Issue 14, 1999, Pages 2397-2405

  Shimada, Hideaki ^a   Germana, Sharon ^a   Sonntag, Kai Christian ^a   Banerjee, Papia ^b   Moore, Daniel ^a   Sachs, David H ^a   LeGuern, Christian ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BioTransplant Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS RNA; VIRUS VECTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; COLONY FORMING UNIT GM; CONTROLLED STUDY; FIBROBLAST CULTURE; GENE THERAPY; IMMUNOLOGICAL TOLERANCE; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; RETROVIRUS; VIRUS GENOME;

3T3 CELLS; ANIMALS; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENES, MHC CLASS II; GENETIC VECTORS; HLA-DQ ANTIGENS; MICE; PROVIRUSES; RETROVIRIDAE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWINE;

ANIMALIA; MURINAE; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0033588965     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017040     Document Type: Article

References (46)

1. ARTELT, P., GRANNEMANN, R., STOCKING, C., FRIEL, J., BARTSCH, J., and HAUSER, H. (1991). The prokaryotic neomycin-resistance-encoding gene acts as a transcriptional silencer in eukaryotic cells. Gene 99, 249-254.
2. AUCHINCLOSS, H.J., and SULTAN, H. (1996). Antigen processing and presentation in transplantation. Curr. Opin. Immunol. 8, 681-687.
3. BACH, F.H., WIDMER, M.B., SEGALL, M., BACH, M.L., and KLEIN, J. (1972). Genetic and immunological complexity of major histocompatibility regions. Science 176, 1024-1030.
4. BANERJEE, P.T., IERINO, F.L., KAYNOR, G.C., GIOVINO, M., HAWLEY, R., ROSA, M.D., LEGUERN, C., SACHS, D.H., and MONROY R. (1997a). Expression of swine MHC class II genes in a cynomolgus monkey: Retrovirus-mediated gene therapy in a pre-clinical transplantation model. Xenotransplantation 4, 174-185.
5. BANERJEE, P.T., KANOR, G.C., MUTHUKUMAR, S., DENARO, M., SHIMADA, H., ZHU, S., ROSA, M.D., SACHS, D.H., and LEGUERN, C. (1997b). A polycistronic retrovirus vector for expression of swine MHC class II DR alpha/beta heterodimers. Xenotransplantation 4, 161-173.
6. BENACERRAF, B. (1981). Role of MHC gene products in immune regulation. Science 212, 1229-1235.
7. CHO, Y.W., CECKA, J.M., and TERASAKI, P.I. (1994). HLA matching effect: Better survival rates and graft quality. Clin. Transplant. 435-449.
8. DAVIS, W.C., PERRYMAN, L.E., and MCGUIRE, T.C. (1984). The Identification and Analysis of Major Functional Populations of Differentiated Cells. R.I. Stern and H.R. Gamble, eds. (Rowman and Allanheld, Totowa, NJ).
9. EMERY, D.W., SHAFER, G.E., KARSON, E.M., SACHS, D.H., and LEGUERN, C. (1993). Retrovirus-mediated transfer and expression of an allogeneic major histocompatibility complex class II DRB cDNA in swine bone marrow cultures. Blood 81, 2460-2465.
10. EMERY, D.W., SABLINSKI, T., SHIMADA, H., GERMANA, S., GIANELLO, P., FOLEY, A., SHULMAN, S., ARN, S., FISHMAN, J., LORF, T., NICKELEIT, V., COLVIN, R.B., SACHS, D.H., and LEGUERN, C. (1997). Expression of an allogeneic MHC DRB transgene, through retroviral transduction of bone marrow, induces specific reduction of alloreactivity. Transplantation 64, 1414-1423.
11. FRASER, C.C., SYKES, M., STANTON-LEE, R., SACHS, D.H., and LEGUERN, C. (1995). Specific unresponsiveness to retrovirally-transferred class I antigen is controlled through the helper pathway. J. Immunol. 154, 1587-1595.
12. GERVAIX, A., LI, X., KRAUS, G., and WONG-STAAL, F. (1997). Multigene antiviral vectors inhibit diverse human immunodeficiency virus type 1 clades. J. Virol. 71, 3048-3053.
13. GIANELLO, P.R., FISHBEIN, J.M., ROSENGARD, B.R., LORF, T., VITIELLO, D.M., ARN, J.S., and SACHS, D.H. (1995). Tolerance to class I-disparate renal allografts in miniature swine. Transplantation 59, 772-777.
14. GUSTAFSSON, K., LEGUERN, C., HIRSCH, F., GERMANA, S., PRATT, K., and SACHS, D.H. (1990). Class II genes of the miniature swine. IV. Characterization and expression of two allelic class II DQB cDNA clones. J. Immunol. 145, 1946-1951.
15. HANTZOPOULOS, P.A., SULLENGER, B.A, UNGERS, G., and GILBOA, E. (1989). Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of the retroviral vector. Proc. Natl. Acad. Sci. U.S.A. 86, 3519-3523.
16. HIRSCH, F., SACHS, D.H., GUSTAFSSON, K., PRATT, K., GERMANA, S., and LEGUERN, C. (1990). Class II of the miniature swine. III. Characterization of an expressed pig class II gene homologous to HLA-DQA. Immunogenetics 31, 52-56.
17. HIRSCH, F., GERMANA, S., GUSTAFSSON, K., PRATT, K., SACHS, D.H., and LEGUERN, C. (1992). Structure and expression of class II A genes in miniature swine. J. Immunol. 149, 841-846.
18. ICHIKAWA, Y., HASHIMOTO, M., NOJIMA, M., SATA, M., FUJIMOTO, N., KYO, M., ISHIBASHI, M., OHSHIMA, S., AMEMIYA, H., FUKUNISHI, T., NAGATO, S., and SONODA, T. (1993). The significant effect of HLA-DRB1 matching on long-term kidney graft outcome. Transplantation 56, 1368-1371.
19. ILVES, H., BARSKE, C., JUNKER, U., BOHNLEIN, E., and VERES, G. (1996). Retroviral vectors designed for targeted expression of RNA polymerase III-driven transcripts: A comparative study. Gene 171, 203-208.
20. JONES, E.Y. (1997). MHC class I and class II structures. Curr. Opin. Immunol. 9, 76-79.
21. JUNKER, U., BOHNLEIN, E., and VERES, G. (1995). Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy. Gene Ther. 2, 639-646.
22. LEGUERN, C., SHIMADA, H., EMERY, D.W., GERMANA, S., and SACHS, D.H. (1993). Molecular transplantation of MHC genes as a means for inducing transplantation tolerance in miniature swine. Bull. Inst. Pasteur 91, 125-133.
23. LEGUERN, C., SHIMADA, H., EMERY, D.W., GERMANA, S., SHAFER, G.E., and SACHS, D.H. (1995). Retrovirus-mediated transfer of MHC class II cDNA into swine bone marrow cells. J. Mol. Med. 73, 269-278.
24. LEIVESTAD, T., BERGER, L., and THORSBY, E. (1992). Beneficial effect of DR matching on cadaveric renal graft survival in Scandia-transplant. Transplant. Proc. 24, 2447-2448.
25. MARKOWITZ, D., GOFF, S., and BANK, A. (1988a). A safe packaging line for gene transfer: Separating viral genes on two different plasmids. J. Virol. 62, 1120-1124.
26. MARKOWITZ, D., GOFF, S., and BANK, A. (1988b). Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167, 400-406.
27. MCKNIGHT, S.L. (1980). The nucleotide sequence and transcript map of the herpes simplex virus thymidine kinase gene. Nucleic Acids Res. 8, 5949-5964.
28. MCWHINNIE, D.L., FUGGLE, S.V., THOMPSON, J.F., WOOD, R.F., and MORRIS, P.J. (1987). The influence of HLA-A,B and -DR matching on leucocyte infiltration in renal allografts. Tissue Antigens 29, 214-223.
29. OPELZ, G., MYTILINEOS, J., SCHERER, S., DUNCKLEY, H., TREJAUT, J., CHAPMAN, J., MIDDLETON, D., SAVAGE, D., FISHER, O., BIGNON, J.-D., BENSA, J.-C., ALBERT, E., and NOREEN, H. (1991). Survival of DNA HLA-DR typed and matched cadaver kidney transplants. Lancet 338, 461-463.
30. PATHACK, V.K., and TEMIN, H.M. (1990). Broad spectrum of in vivo forward mutation, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: Substitutions, frameshifts, and hypermutations. Proc. Natl. Acad. Sci. U.S.A. 87, 6019-6023.
31. PESCOVITZ, M.D., LUNNEY, J.K., and SACHS, D.H. (1984). Preparation and characterization of monoclonal antibodies reactive with porcine PBL. J. Immunol. 133, 368-375.
32. PIERRES, M., KOURILSKY, F.M., REBOUAH, J.-P., DOSSETO, M., and CAILLOL, D. (1980). Distinct epitopes of Ik gene products identified by monoclonal antibodies. Eur. J. Immunol. 10, 950-957.
33. POGULIS, R.J., and PEASE, L.R. (1998). A retroviral vector that directs simultaneous expression of alpha and beta T cell receptor genes. Hum. Gene Ther. 9, 2299-2304.
34. PUNSINELLI, G.A., and TEMIN, H.M. (1991). Characterization of large deletion occurring during a single round of retrovirus vector replication: Novel deletion mechanism involving errors in strand transfer. J. Virol. 65, 4786-4792.
35. ROSENGARD, B.R., OJIKUTU, C.A., GUZZETTA, P.C., SMITH, C.V., SUNDT, T.M., III, NAKAJIMA, K., BOORSTEIN, S.M., HILL, G.S., FISHBEIN, J.M., and SACHS, D.H. (1992). Induction of specific tolerance to class I-disparate renal allografts in miniature swine with cyclosporine. Transplantation 54, 490-497.
36. SACHS, D.H., SMITH, C.V., EMERY, D.W., LEGUERN, C., BODINE, D.M., NIENHUIS, A., and SYKES, M. (1993). Induction of specific tolerance to MHC-disparate allografts through genetic engineering. Exp. Nephrol. 1, 128-133.
37. SAMBROOK, J., FRISCH, E.F., and MANIATIS, T. (1989). Molecular Cloning: A Laboratory Manual. C. Nolan, ed. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
38. SHAFER, G.E., EMERY, D.W., GUSTAFSSON, K., GERMANA, S., ANDERSON, W.F., SACHS, D.H., and LEGUERN, C. (1991). Expression of a swine class II gene in murine bone marrow hematopoietic cells by retroviral-mediated gene transfer. Proc. Natl. Acad. Sci. U.S.A. 88, 9760-9764.
39. SUNDT, T.M., III, and SACHS, D.H. (1988). Applications of molecular biology to transplantation tolerance. Immunol. Today 9, 342-343.
40. SYKES, M., SACHS, D.H., NIENHUIS, A.W., PEARSON, D.A., MOULTON, A.D., and BODINE, D.M. (1993). Specific prolongation of skin graft survival following retroviral transduction of bone marrow with an allogeneic major histocompatibility complex gene. Transplantation 55, 197-202.
41. VALERA, A., PERALES, J.C., HATZOGLOU, M., and BOSCH, F. (1994). Expression of the neomycin-resistance (neo) gene induces alterations in gene expression and metabolism. Hum. Gene Ther. 5, 449-456.
42. WIGLER, M., SWEET, R., SIM, G.K., WOLD, B., PELLICER, A., LACY, E., MANIATIS, T., SILVERSTEIN, S., and AXEL, R. (1979). Transformation of mammalian cells with genes from procaryotes and eucaryotes. Cell 16, 777-785.
43. WIZNEROWICZ, M., FONG, A.Z., MACKIEWICZ, A., and HAWLEY, R.G. (1997). Double-copy bicistronic retroviral vector platform for gene therapy and tissue engineering: Application to melanoma vaccine development. Gene Ther. 4, 1061-1068.
44. WOLFE, J.H., KYLE, J.W., SANDS, M.S., SLY, W.S., MARKOWITZ, D.G., and PARENTE, M.K. (1995). High level expression and export of beta-glucuronidase from murine mucopolysaccharidosis VII cells corrected by a double-copy retrovirus vector. Gene Ther. 2, 70-78.
45. ZHANG, J., and TEMIN, H.M. (1994). Retrovirus recombination depends on the length of sequence identity and is not error prone. J. Virol. 68, 2409-2416.
46. ZITVOGEL, L., TAHARA, H., CAI, Q., STORKUS, W.J., MULLER, G., WOLF, S.F., GATELY, M., ROBBINS, P.D., and LOTZE, M.T. (1994). Construction and characterization of retroviral vectors expressing biologically active human interleukin-12. Hum. Gene Ther. 5, 1493-1506.